Searchable abstracts of presentations at key conferences in endocrinology

ea0022p565 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Daily temozolomide therapy in Nelson's syndrome

Ortiga Ruth Sanchez , Sanchez Victor L Gonzalez , Perez Oscar Moreno , Meana Andres , Alfonso Antonio A Pico

Temozolomide, an alkylating agent used in malignant gliomas, has been recently used too in the treatment of aggressive pituitary tumors. To date, two cases of Nelson’s syndrome has successfully treated with 5 days of 28-day cycle, but the follow-up has been shorter than 12 months. We reported the third patient with Nelson’s syndrome treated with temozolomide, who after an initial goal response to three 300 mg 5 days of 28-day cycles shown a clinical and biochemical (...

ea0037ep669 | Pituitary: basic and neuroendocrinology | ECE2015

MiR-7 has a role in behaviour of somatotroph adenomas

Sanchez-Ortiga Ruth , Sanchez-Tejada Laura , Lamas Cristina , Camara Rosa , Abarca Javier , Monjas Irene , Riesgo Pedro , Fajardo Carmen , Pico Antonio

Purpose: IGF receptor 1 (IGF1R) and epidermal growth factor receptor (EGFR) are receptors tyrosine-kinase (RTK) whose altered signaling are critical factors in development of many types of tumours. These RTK are some of the main targets of the microRNA miR-7. This important tumor supressor miRNA has the ability to inhibit the motility, invasiveness and anchorage-independent growth, suggesting a strong therapeutic potential in many types of cancer. Pituitary adenomas (PA) are a...

ea0037gp.18.08 | Pituitary–Basic and IGF-1 | ECE2015

Role of miR-375 in oncogenesis of pituitary adenomas

Sanchez-Tejada Laura , Sanchez-Ortiga Ruth , Riesgo Pedro , Abarca Javier , Fajardo Carmen , Monjas Irene , Camara Rosa , Lamas Cristina , Pico Antonio

Purpose: MicroRNAs (miRNAs) are a fundamental component of gene regulation mechanisms. Presently, altered miRNA patterns of expression have been documented in different human cancers, and they may explain the distinct behavior of pituitary adenomas (PA) and the differences between subtypes. miR-375 can target among other genes to IGF1 receptor (IGF1R) and participes in reprogramming cancer cell metabolism. The aim of this study was to assess the miR-375 role on pathogenesis of...

ea0037gp.18.09 | Pituitary–Basic and IGF-1 | ECE2015

Molecular classification of pituitary adenomas

Pico Antonio , Sanchez-Tejada Laura , Sanchez-Ortiga Ruth , Camara Rosa , Lamas Cristina , Abarca Javier , Monjas Irene , Riesgo Pedro , Fajardo Carmen

Purpose: The 2004 edition of the WHO text ‘Histological typing of endocrine tumors’ classified pituitary adenomas (PA) on the basis of their histological and immunohistochemical characteristics. Recent advances on the knowledge of the molecular patterns of these tumours may allow establishing a molecular classification with higher accuracy and specificity than previous one.Methods: Within the pale of the multicenter Spanish Molecular Registry o...

ea0032p908 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Sleep-apnea and cardiomyopathy in acromegalic patients

Sanchez-Ortiga Ruth , Candela Alfredo , Climent Vicente , Sanchez-Tejada Laura , Monjas-Canovas Irene , Abarca Javier , Moreno-Perez Oscar , Pico Antonio

Introduction: Sleep disordered breathing (SDB) promotes structural myocardial changes and can trigger cardiac arrhythmias. Acromegalic patients have high prevalence of SDB and GH–IGF1 excess is related to a specific cardiomyopathy characterized by concentric cardiac hypertrophy and diastolic dysfunction. The aim of this study was to assess the relationship between SDB and cardiac dysfunction on acromegalic patients.Material and methods: Observationa...

ea0022p597 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Contribution of the molecular biology to the study of the behaviour of pituitary adenomas

Sanchez-Tejada Laura , Sanchez-Ortiga Ruth , Niveiro Maria , Peiro Gloria , Moreno Oscar , Aranda Ignacio , Alfonso Antonio A Pico

Background: There is an increasing interest to find specific prognostic markers of the aggressive behaviour of some pituitary adenomas (PA). The most studied markers have been the immunohistochemical staining for Ki-67 and p53. The aim of this study was to evaluate the relevance as possible prognostic markers of growth factors (IGF1R), angiogenic factors (VEGF and his receptor) and new genes (PTTG) versus the immunohistochemical expression of Ki-67 and p53 in PA.<p class="...

ea0022p602 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Application of the human chorionic gonadotropin immunoassay in cerebrospinal fluid for the diagnostic work-up of neurohypophyseal germinomas

Gonzalez-Sanchez Victor Luis , Moreno-Perez Oscar , Pellicer Pedro Sanchez , Sanchez-Ortiga Ruth , Dot Monserrat Mauri , Simeon Elena Gastaldo , Lopez Ignacio Aranda , Alfonso Antonio Miguel Pico

Context: The determination of human chorionic gonadotropin (hCG) in cerebrospinal fluid (CSF) is useful for the differential diagnosis of suprasellar lesions. However, the concentrations that prove diagnostic for neurohypophyseal germinoma have not been well defined. In addition, the immunoassays used for such determination are the same as those applied in serum, and few studies have been performed regarding the validation of such techniques in CSF.Objec...

ea0022p532 | Male reproduction | ECE2010

Validation of salivary testosterone as a diagnostic test in the hypothalamic–pituitary–gonadal axis diseases

Moreno-Perez Oscar , Gonzalez-Sanchez Victor Luis , Romualdo Luis Garcia de Guadiana , Sanchez-Ortiga Ruth , Guerra Rocio Alfayate , Dot Monserrat Mauri , Alfonso Antonio Miguel Pico

Introduction: Salivary testosterone (Sal-T) reflects the plasma free testosterone fraction that can flow passively through the salivary glands and appears to be a strong correlation with the Calculated free testosterone (CFT) in both eugonadal and hypogonadal men. Since the collection of saliva is simple, noninvasive and inexpensive, the Sal-T is a promising tool for the screening of hypogonadism. Despite the initial interest that Sal-T has aroused, new clinical studies are ne...

ea0032p844 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Spanish molecular registry of pituitary adenomas: a multicenter, translational approach aimed at improving patient management

Leal-Cerro Alfonso , Luque Raul M , Sanchez-Tejada Laura , Ibanez-Costa Alejandro , Jorda Mireia , Galvez Maria A , Japon Miguel A , Rivero-Cortes Esther , Sanchez-Ortiga Ruth , Buj Raquel , Venegas Eva , Dios Elena , Webb Susan M , Soto-Moreno Alfonso , Fajardo Carmen , Bernabeu Ignacio , Benito-Lopez Pedro , Puig-Domingo Manel , Pico Antonio , Castano Justo P

Pituitary adenomas are heterogeneous, rare tumors, which hinders analysis of large numbers of cases with common approaches. To overcome this, a multicenter, clinical-basic strategy was proposed aimed at enhancing the tools to diagnose and manage pituitary tumors by combining clinical/pathological/molecular information. This initiative was developed by the Sociedad Andaluza de Endocrinología y Nutrición, and further endorsed by the Sociedad Española de Endocrinol...

ea0029p1435 | Pituitary Clinical | ICEECE2012

Experience in the use of tolvaptan in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Zamuner M. Mijares , Sanchez-Pacheco M. , Tardon , Gotarredona J. Serrano , Perez O. Moreno , Avella G. Negueruela , Vidal R. Cerezo , Ortiga R. Sanchez , Alfonso A. Pico

Introduction: Hyponatremia is the most common electrolyte disorder in hospitalized patients. SIADH is characterized by euvolemic hyponatremia with sodium and urine osmolality inappropriately high. The selective antagonist of the vasopressin V2 receptor (tolvaptan) helps to eliminate water free of solute (aquaresis), being effective in treating this condition.Objetive: Evaluate the efficacy and safety of tolvaptan in the treatment of SIADH.<p class="a...